Skip to main content

JANE STREET GROUP, LLC

Position in VCEL — Vericel Corp

CIK 1595888 NEW YORK, NY

Position in VCEL

as of Mar 31, 2026 · filed May 12, 2026
Position Value
$13,187,447
+$13,187,447 QoQ
Shares Held
409,930
Ownership
0.803%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in VCEL Over Time

Shares Held

Position Value (USD)

Derivatives in VCEL

reported options exposure · as of Dec 31, 2025
CallValue
$558,155
CallShares
15,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

JANE STREET GROUP, LLC holds $1,253,826,569 across 316 Biotechnology names. VCEL ranks #24 (1.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VCEL

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $13,187,447 409,930
2025-12-31 $558,155 15,500
2025-09-30 $2,091,653 66,465
2025-06-30 $536,130 12,600
2025-06-30 $1,082,812 25,448
2025-03-31 $3,508,559 78,632
2025-03-31 $539,902 12,100
2024-12-31 $549,100 10,000
2024-12-31 $2,970,466 54,097
2024-09-30 $249,275 5,900
2024-09-30 $4,397,971 104,094
2024-06-30 $3,443,614 75,057
2024-03-31 $529,875 10,186
2023-12-31 $299,408 8,408
2023-09-30 $332,417 9,917
2023-06-30 $1,713,267 45,602
2023-03-31 $2,050,318 69,929
2022-03-31 $280,687 7,344
2021-12-31 $526,620 13,400
2021-12-31 $292,588 7,445
2021-09-30 $366,000 7,500
2021-06-30 $1,100,610 20,964
2021-06-30 $966,000 18,400
2021-03-31 $286,749 5,162
2020-12-31 $1,178,318 38,158
2020-09-30 $422,206 22,785
2020-06-30 $285,285 20,643
2020-03-31 $104,272 11,371